Literature DB >> 17462393

Does normothermic normokalemic simultaneous antegrade/retrograde perfusion improve myocardial oxygenation and energy metabolism for hypertrophied hearts?

Jian Wang1, Hongyu Liu, Tomas A Salerno, Bo Xiang, Gang Li, Marco Gruwel, Michael Jackson, Darren Manley, Boguslaw Tomanek, Roxanne Deslauriers, Ganghong Tian.   

Abstract

BACKGROUND: Beating-heart valve surgery appears to be a promising technique for protection of hypertrophied hearts. Normothermic normokalemic simultaneous antegrade/retrograde perfusion (NNSP) may improve myocardial perfusion. However, its effects on myocardial oxygenation and energy metabolism remain unclear. The present study was to determine whether NNSP improved myocardial oxygenation and energy metabolism of hypertrophied hearts relative to normothermic normokalemic antegrade perfusion (NNAP).
METHODS: Twelve hypertrophied pig hearts underwent a protocol consisting of three 20-minute perfusion episodes (10 minutes NNAP and 10 minutes NNSP in a random order) with each conducted at a different blood flow in the left anterior descending coronary artery (LAD [100%, 50%, and 20% of its initial control]). Myocardial oxygenation was assessed using near-infrared spectroscopic imaging. Myocardial energy metabolism was monitored using localized phosphorus-31 magnetic resonance spectroscopy.
RESULTS: With 100% LAD flow, both NNAP and NNSP maintained myocardial oxygenation, adenosine triphosphate, phosphocreatine, and inorganic phosphate at normal levels. When LAD flow was reduced to 50% of its control level, NNSP resulted in a small but significant decrease in myocardial oxygenation and phosphocreatine, whereas those measurements did not change significantly during NNAP. With LAD flow further reduced to 20% of its control level, both NNAP and NNSP caused a substantial decrease in myocardial oxygenation, adenosine triphosphate, and phosphocreatine with an increase in inorganic phosphate. However, the changes were significantly greater during NNSP than during NNAP.
CONCLUSIONS: Normothermic normokalemic simultaneous antegrade/retrograde perfusion did not improve, but slightly impaired myocardial oxygenation and energy metabolism of beating hypertrophied hearts relative to NNAP. Therefore, NNSP for protection of beating hypertrophied hearts during valve surgery should be used with extra caution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462393     DOI: 10.1016/j.athoracsur.2007.01.026

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Minimally invasive approach for redo mitral valve surgery.

Authors:  Luca Botta; Aldo Cannata; Giuseppe Bruschi; Pasquale Fratto; Corrado Taglieri; Claudio Francesco Russo; Luigi Martinelli
Journal:  J Thorac Dis       Date:  2013-11       Impact factor: 2.895

2.  Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.

Authors:  Junxia Li; Longmei Wu; Xinli Tian; Jian Zhang; Yujie Shi
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

3.  Preservation of Myocardial Perfusion and Function by Keeping Hypertrophied Heart Empty and Beating for Valve Surgery: An In Vivo MR Study of Pig Hearts.

Authors:  Jian Wang; Bo Xiang; Jixian Deng; Hung-Yu Lin; Darren H Freed; Rakesh C Arora; Ganghong Tian
Journal:  Biomed Res Int       Date:  2017-03-20       Impact factor: 3.411

4.  Mini-thoracotomy in redo mitral valve surgery: safety and efficacy of a standardized procedure.

Authors:  Filippo Prestipino; Riccardo D'Ascoli; Ádám Nagy; Gianluca Paternoster; Erica Manzan; Giampaolo Luzi
Journal:  J Thorac Dis       Date:  2021-09       Impact factor: 2.895

5.  Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention.

Authors:  Le Wang; Gang Liu; Jun Liu; Mingqi Zheng; Liang Li
Journal:  Ther Clin Risk Manag       Date:  2016-06-24       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.